Imagin Medical Engages Torrey Hills Capital
January 20, 2021 08:30 ET
|
Imagin Medical Inc.
VANCOUVER, British Columbia, and BOSTON, Jan. 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (FSE: DPD2) ("Imagin" or the "Company") is pleased to...
Imagin Medical Builds Momentum for 2021
January 13, 2021 08:30 ET
|
Imagin Medical Inc.
VANCOUVER, British Columbia, and BOSTON, Jan. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical (CSE: IME) (OTC: IMEXF) (FRA: DPD2) (the “Company”) announces that critical milestones...
InvestorBrandNetwork (IBN) Coverage Initiated for Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF)
January 13, 2021 08:30 ET
|
InvestorBrandNetwork (IBN)
NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF), a surgical imaging company focused on establishing a new standard of care in visualizing...
bioAffinity Licenses CyPath® Lung to Precision Pathology Services
October 10, 2018 12:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced a licensing agreement with Precision Pathology Services for the continued...
Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology
June 19, 2018 07:38 ET
|
Precipio, Inc.
Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, Conn., June 19, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO),...
bioAffinity Technologies Welcomes Peter S. Knight to Board of Directors
May 14, 2018 10:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, May 14, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Peter S....
Imagin Medical Announces Private Placement
April 03, 2018 08:00 ET
|
Imagin Medical Inc.
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive...
bioAffinity Technologies to Present at Biotech Showcase™ Annual Conference
January 05, 2018 09:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, Jan. 05, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced that it will present its proprietary technology to detect...
Liquid Biopsy Tools, Diagnostics Market to Reach $4.5B by 2022
October 10, 2017 15:45 ET
|
BCC Research
WELLESLEY, Mass., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Liquid biopsy is rapidly gaining traction as a supplement or alternative to tissue biopsy, with the potential to attain a global market value of...
Electro-Optical Sciences to Commemorate Melanoma Monday at NASDAQ Stock Market
April 30, 2009 16:01 ET
|
Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - April 30, 2009) - Electro-Optical Sciences (NASDAQ: MELA) today
announced that the company will ring the NASDAQ Stock Market Opening Bell
on Monday, May 4, 2009 at 9:30...